There are currently 16 active clinical trials seeking participants for Ventricular Tachycardia research studies. The states with the highest number of trials for Ventricular Tachycardia participants are California, New York, Texas and Pennsylvania.
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
NCT06005428
Recruiting
This is a Phase 2, multicenter, double-blind, sponsor unblinded, placebo-controlled, single-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CRD-4730 when administered as single oral doses to participants with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). The study will have 2 cohorts in which participants with CPVT will participate in a 3-period, randomized 2-sequence study. Each participant will receive 2... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
06/07/2024
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio +11 locations
Conditions: CPVT1, Heart Defects, Congenital, Heart Diseases, Ventricular Tachycardia
Register for Updates
MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry
NCT06455488
Recruiting
Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/11/2024
Locations: Corvita Science Foundation, Chicago, Illinois
Conditions: Ventricular Tachycardia
Register for Updates
Assessment of Combined CCM and ICD Device in HFrEF
NCT05855135
Recruiting
The goal of this clinical trial is to demonstrate that the OPTIMIZER® Integra CCM-D System (the "CCM-D System") can safely and effective convert induced ventricular fibrillation (VF) and spontaneous ventricular tachycardia and/or ventricular fibrillation (VT/VF) episodes in subjects with Stage C or D heart failure who remain symptomatic despite being on guideline-directed medical therapy (GDMT), are not indicated for cardiac resynchronization therapy (CRT), and have heart failure with reduced le... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/10/2024
Locations: CardioVascular Associates of Mesa, Mesa, Arizona +27 locations
Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction, Implantable Defibrillator User, CCM Therapy, Non-ischemic Cardiomyopathy, Ischemic Cardiomyopathy, Sudden Cardiac Arrest, Arrhythmias, Cardiac, Ventricular Tachycardia, Ventricular Fibrillation
Register for Updates
Abbott Ventricular Tachycardia PAS
NCT05839873
Recruiting
This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospective, single arm, open-label, multi-center, observational study.
Gender:
All
Ages:
7 years and above
Trial Updated:
05/28/2024
Locations: Aurora Denver Cardiology Associates, Aurora, Colorado +13 locations
Conditions: Ventricular Tachycardia
Register for Updates
The Z Stitch Early Bed Rest Assessment Study
NCT06087497
Recruiting
The goal of this study is to understand the effects of early mobilization after a Z stitch procedure in patients undergoing certain heart-related treatments. The investigators want to find out if allowing patients to move around sooner after their procedure can improve their satisfaction and potentially lead to earlier discharge from the hospital. Type of Study: Clinical Trial Participant Population/Health Conditions: Patients aged 18-99 undergoing specific heart procedures such as atrial fibr... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
04/11/2024
Locations: Oregon Health and Science University, Portland, Oregon +1 locations
Conditions: Atrial Fibrillation, Atrial Flutter, Supraventricular Tachycardia, Syncope, Ventricular Tachycardia
Register for Updates
Mayo AVC Registry and Biobank
NCT03049254
Recruiting
Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death is the most tragic and dangerous. Diagnosis and screening of blood-relatives is very difficult as the disease process can be subtle, but sufficient enough, so that the first event is sudden death. The Mayo Clinic AVC Registry is a collaboration between Mayo Clinic, Rochester, USA and Papworth Hospital, Cambridg... Read More
Gender:
All
Ages:
All
Trial Updated:
03/22/2024
Locations: Mayo Clinic, Rochester, Minnesota +1 locations
Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiomyopathies, Heart Diseases, Cardiovascular Diseases, Sudden Cardiac Arrest, Sudden Cardiac Death, Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Ventricular Cardiomyopathy, Familial Dilated Cardiomyopathy, Cardiovascular Abnormalities, Sarcoidosis, Cardiac Arrhythmia, Cardiac Sarcoidosis, Myocarditis, Inflammatory Cardiomyopathy, Ventricular Tachycardia, Right Ventricular Outflow Tract Ventricular Tachycardia
Register for Updates
Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
NCT01013714
Recruiting
The purpose of this research study is to examine the effect of cardiac sympathetic denervation (CSD) surgery on life threatening abnormal heart rhythms called ventricular tachycardia or ventricular fibrillation that can lead to sudden cardiac death. Subjects will be asked to participate in this research study if they have recurrent ventricular tachycardia (at least one ICD shock for ventricular tachycardia) and have undergone at least one catheter ablation procedure or have ventricular tachycard... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/17/2024
Locations: UCLA Health, Los Angeles, California +2 locations
Conditions: Sudden Cardiac Death, Ventricular Tachycardia, Ventricular Fibrillation, Cardiomyopathy
Register for Updates
Outcomes of Functional Substrate Mapping of Ventricular Tachycardia
NCT05708131
Recruiting
The goal of this registry database is to demonstrate the safety and effectiveness of functional ventricular tachycardia (VT) ablation using SENSE protocol in patients with ischaemic VT. Mortality and the need for ICD therapies at 12 months post-ablation will be compared with propensity-matched controls undergoing substrate-based ablation alone.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/11/2024
Locations: Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania +7 locations
Conditions: Ventricular Tachycardia
Register for Updates
Venous Ethanol for Ventricular Tachycardia
NCT05511246
Recruiting
Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
12/28/2023
Locations: Houston Methodist Hospital, Houston, Texas
Conditions: Ventricular Tachycardia, Ischemic Cardiomyopathy
Register for Updates
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
NCT05377216
Recruiting
Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/23/2023
Locations: Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
Conditions: Ventricular Tachycardia
Register for Updates
Ablation at Virtual-hEart pRedicted Targets for VT
NCT03536052
Recruiting
The goal of this study is to test the efficacy of the new imaging/simulation ("virtual heart") approach for determining the optimal ablation sites in patients with VT, which render post-infarction VT non-inducible. The study will test both the acute outcome of the ablation procedure, and the effect the use of the predicted targets has upon procedure time.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/25/2023
Locations: Johns Hopkins, Baltimore, Maryland
Conditions: Ventricular Tachycardia, Ischemic Cardiomyopathy
Register for Updates
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
NCT04496518
Recruiting
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).
Gender:
All
Ages:
All
Trial Updated:
08/29/2023
Locations: Alaska Heart, Anchorage, Alaska +112 locations
Conditions: Ventricular Tachycardia
Register for Updates